Inflammatory
-
If you suffer from inflammatory bowel disease (IBD), a pill full of tiny algae robots may be just what you need. The bio-hybrid microrobots have already been shown to reduce symptoms and promote healing in IBD-afflicted lab mice.
-
A new study has overturned traditional thinking about regulatory T cells, which suppress the body’s inflammatory response, and has significant implications for treating a wide range of conditions, from repairing injured muscles to regrowing hair.
-
For the first time, a major trigger in inflammatory bowel disease (IBD) and related conditions has been identified, and existing drugs are capable of blocking it. It's a "massive step" in successfully treating these debilitating lifelong conditions.
-
A new drug for severe influenza successfully keeps patients at the perfect level of lung inflammation to protect against lung damage while still allowing the immune system to fight off the infection. It's effective in mice even days after infection.
-
As common as asthma is, exactly how it starts remains murky. Scientists have now identified a new root cause, and importantly a new angle for treating the disease that can prevent the main symptoms.
-
Giving infliximab, an immunotherapy drug, as soon as possible after diagnosis with Crohn’s disease significantly reduced complications, including the need for urgent surgery by a factor of 10, a clinical study has found.
-
Ever since SARS-CoV-2 emerged, the virus has been known for its novel effects on the brain. But exactly how is it causing these symptoms? A new study suggests that the answer lies in the way our vagus nerve talks to the brain.
-
Researchers have developed drug-loaded nanoparticles that target the cells that cause damaging inflammation following a spinal cord injury. The novel nanotherapy opens the door to new therapeutic possibilities for people with spinal injuries.
-
A drug currently used as a second- or third-line treatment for those with rheumatoid arthritis has shown huge promise as a preventative, stopping the onset of the debilitating and painful disease in 92.8% of at-risk participants after 12 months.
-
In yet another surprise attribute of the new class of obesity drugs, scientists have found that GLP-1 receptor agonists can also subdue brain inflammation, giving them a potential ‘superpower’ in the fight against Alzheimer’s and Parkinson’s diseases.
-
Researchers have worked with biology rather than against it, fitting microparticle 'backpacks' to important inflammatory cells called macrophages to significantly reduce lesion size and inflammation caused by traumatic brain injury.
-
Researchers have developed a novel anti-inflammatory from a Southeast Asian medicinal plant that doesn’t suppress the immune system like currently used corticosteroids do, opening the door to a new class of anti-inflammatory drugs.
Load More